222 related articles for article (PubMed ID: 36830294)
1. Meropenem Model-Informed Precision Dosing in the Treatment of Critically Ill Patients: Can We Use It?
Li L; Sassen SDT; Ewoldt TMJ; Abdulla A; Hunfeld NGM; Muller AE; de Winter BCM; Endeman H; Koch BCP
Antibiotics (Basel); 2023 Feb; 12(2):. PubMed ID: 36830294
[TBL] [Abstract][Full Text] [Related]
2. Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.
Schatz LM; Brinkmann A; Röhr A; Frey O; Greppmair S; Weinelt F; Zoller M; Scharf C; Hempel G; Liebchen U
Antimicrob Agents Chemother; 2023 May; 67(5):e0010423. PubMed ID: 37125925
[TBL] [Abstract][Full Text] [Related]
3. External Evaluation of Population Pharmacokinetic Models to Inform Precision Dosing of Meropenem in Critically Ill Patients.
Yang N; Wang J; Xie Y; Ding J; Wu C; Liu J; Pei Q
Front Pharmacol; 2022; 13():838205. PubMed ID: 35662716
[TBL] [Abstract][Full Text] [Related]
4. Model-Informed Therapeutic Drug Monitoring of Meropenem in Critically Ill Patients: Improvement of the Predictive Ability of Literature Models with the PRIOR Approach.
Chan Kwong A; O'Jeanson A; Khier S
Eur J Drug Metab Pharmacokinet; 2021 May; 46(3):415-426. PubMed ID: 33830470
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of a precision dosing software program for predicting antibiotic concentrations in critically ill patients.
Chai MG; Roberts JA; Farkas A; Cotta MO
J Antimicrob Chemother; 2023 Feb; 78(2):354-358. PubMed ID: 36454242
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic drug monitoring of cefepime in a non-critically ill population: retrospective assessment and potential role for model-based dosing.
Suttels V; André P; Thoma Y; Veuve F; Decosterd L; Guery B; Buclin T
JAC Antimicrob Resist; 2022 Apr; 4(2):dlac043. PubMed ID: 35465238
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics and evaluation of the predictive performance of pharmacokinetic models in critically ill patients receiving continuous infusion meropenem: a comparison of eight pharmacokinetic models.
Dhaese SAM; Farkas A; Colin P; Lipman J; Stove V; Verstraete AG; Roberts JA; De Waele JJ
J Antimicrob Chemother; 2019 Feb; 74(2):432-441. PubMed ID: 30376103
[TBL] [Abstract][Full Text] [Related]
8. Impact of cumulative fluid balance on the pharmacokinetics of extended infusion meropenem in critically ill patients with sepsis.
Pařízková RČ; Martínková J; Havel E; Šafránek P; Kaška M; Astapenko D; Bezouška J; Chládek J; Černý V
Crit Care; 2021 Jul; 25(1):251. PubMed ID: 34274013
[TBL] [Abstract][Full Text] [Related]
9. Software- and TDM-Guided Dosing of Meropenem Promises High Rates of Target Attainment in Critically Ill Patients.
Chiriac U; Richter D; Frey OR; Röhr AC; Helbig S; Hagel S; Liebchen U; Weigand MA; Brinkmann A
Antibiotics (Basel); 2023 Jun; 12(7):. PubMed ID: 37508207
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of therapeutic drug monitoring of piperacillin and meropenem in routine clinical practice: a prospective cohort study in critically ill patients.
Schoenenberger-Arnaiz JA; Ahmad-Diaz F; Miralbes-Torner M; Aragones-Eroles A; Cano-Marron M; Palomar-Martinez M
Eur J Hosp Pharm; 2020 Mar; 27(e1):e30-e35. PubMed ID: 32296502
[TBL] [Abstract][Full Text] [Related]
11. Towards model-informed precision dosing of piperacillin: multicenter systematic external evaluation of pharmacokinetic models in critically ill adults with a focus on Bayesian forecasting.
Greppmair S; Brinkmann A; Roehr A; Frey O; Hagel S; Dorn C; Marsot A; El-Haffaf I; Zoller M; Saller T; Zander J; Schatz LM; Scharf C; Briegel J; Minichmayr IK; Wicha SG; Liebchen U
Intensive Care Med; 2023 Aug; 49(8):966-976. PubMed ID: 37439872
[TBL] [Abstract][Full Text] [Related]
12. Impact of Inaccurate Documentation of Sampling and Infusion Time in Model-Informed Precision Dosing.
Alihodzic D; Broeker A; Baehr M; Kluge S; Langebrake C; Wicha SG
Front Pharmacol; 2020; 11():172. PubMed ID: 32194411
[TBL] [Abstract][Full Text] [Related]
13. Population PK/PD modelling of meropenem in preterm newborns based on therapeutic drug monitoring data.
Zyryanov S; Bondareva I; Butranova O; Kazanova A
Front Pharmacol; 2023; 14():1079680. PubMed ID: 37007022
[No Abstract] [Full Text] [Related]
14. Model-informed precision dosing of vancomycin via continuous infusion: a clinical fit-for-purpose evaluation of published PK models.
Heus A; Uster DW; Grootaert V; Vermeulen N; Somers A; In't Veld DH; Wicha SG; De Cock PA
Int J Antimicrob Agents; 2022 May; 59(5):106579. PubMed ID: 35341931
[TBL] [Abstract][Full Text] [Related]
15. Optimising meropenem dosing in critically ill Australian Indigenous patients with severe sepsis.
Tsai D; Stewart P; Goud R; Gourley S; Hewagama S; Krishnaswamy S; Wallis SC; Lipman J; Roberts JA
Int J Antimicrob Agents; 2016 Nov; 48(5):542-546. PubMed ID: 27771187
[TBL] [Abstract][Full Text] [Related]
16. Development of a dosing algorithm for meropenem in critically ill patients based on a population pharmacokinetic/pharmacodynamic analysis.
Ehmann L; Zoller M; Minichmayr IK; Scharf C; Huisinga W; Zander J; Kloft C
Int J Antimicrob Agents; 2019 Sep; 54(3):309-317. PubMed ID: 31229669
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the accuracy and precision of pharmacokinetic equations to predict free meropenem concentrations in critically ill patients.
Wong G; Farkas A; Sussman R; Daroczi G; Hope WW; Lipman J; Roberts JA
Antimicrob Agents Chemother; 2015 Mar; 59(3):1411-7. PubMed ID: 25512414
[TBL] [Abstract][Full Text] [Related]
18. Population Pharmacokinetic Meta-Analysis and Dosing Recommendation for Meropenem in Critically Ill Patients Receiving Continuous Renal Replacement Therapy.
Peng Y; Cheng Z; Xie F
Antimicrob Agents Chemother; 2022 Sep; 66(9):e0082222. PubMed ID: 36005753
[TBL] [Abstract][Full Text] [Related]
19. Assessing the predictive performance of population pharmacokinetic models for intravenous polymyxin B in critically ill patients.
Hanafin PO; Nation RL; Scheetz MH; Zavascki AP; Sandri AM; Kwa AL; Cherng BPZ; Kubin CJ; Yin MT; Wang J; Li J; Kaye KS; Rao GG
CPT Pharmacometrics Syst Pharmacol; 2021 Dec; 10(12):1525-1537. PubMed ID: 34811968
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of meropenem in critically ill patients with severe infections.
Binder L; Schwörer H; Hoppe S; Streit F; Neumann S; Beckmann A; Wachter R; Oellerich M; Walson PD
Ther Drug Monit; 2013 Feb; 35(1):63-70. PubMed ID: 23318279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
